QMC exits Corporación Dermoestética
QMC Development Capital Fund is divesting Corporación Dermoestética.
QMC announced its investment in the firm in 2006 and was the third shareholder with 5.12% until last March.
Since March, the fund, which is managed by N+1, sold almost half of its stake for more than €750,000 and will be listing the remaining 2.7%.
Among Dermoestética's major shareholders is the firm’s chairman José Maria Suescun, who holds 50.43%, and Banco de Valencia, with 8.67%.
Company
Corporación Dermoestética operates around 50 clinics throughout Portugal and Spain. It offers cosmetic, plastic and reconstructive surgical procedures, as well as nutritional and cosmetic dentistry services. The firm also produces and markets cosmetic products.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater